Moleculin Reports First Quarter 2022 Financial Results and Provides Programs Update
Go back to Moleculin Reports First Quarter 2022 Financial Results and Provides Programs Update| METABASIS THERAPEUT (NASDAQ: MBRX) | Delayed: 0.61 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.61 | 52 Week High | $9.58 | |||
| Open | $0.61 | 52 Week Low | $2.34 | |||
| Day High | $0.61 | P/E | N/A | |||
| Day Low | $0.61 | EPS | $-0.34 | |||
| Volume | 22,256 | |||||
